Naslov
The review of the questionnaire about the effectiveness of Sumatriptane

Autori
Strahinja, Višnja ; Willheim, Ksenija ; Šepić Grahovac, Dubravka

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Abstracts / - Beč : International Pharmaceutical Federation (FIP), 2000

Skup
Pharmacy World Congress 2000

Mjesto i datum
Beč, Austrija, 26.08.2000. - 31.08.2000

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Migraine; Sumatriptane

Sažetak
We wanted to evaluate the effectiveness of sumatriptane by analysing the questionnaire filled by patients suffering from migraine. The questionnaire consisted of four questions: which dosage of sumatriptane do you use in migraine attacks? How would you evaluate the effectiveness of this dosage of sumatriptane? Account all other drugs you used before in treating migraine attacks? How would you evaluate the effectiveness of those drugs in comparison to sumatriptane? We analysed 97 questionnaires and found: 47% of patients used 50 mg sumatriptane, 43% used 100 mg, and 10% used 200 mg sumatriptane. The dosage is excellent in 68%, good in 28% and inefficient in 10 patients. Before sumatriptane 64% used dihydroergotamine, 28% caffetine, 10% Aspirine and 10% noraminophenasone. 89% said sumatriptane is more efficient, 4% thought that the efficiency is the same, and 7% evaluated lesser effectiveness.The questionnaire showed that 50, 100 mg of sumatriptane is enough for a desired effect, 90% of patients evaluated excellent or good efficiency of sumatriptane, 89% as a far more efficient. We should have more analogue questionnaires for drugs which are on the market more than five years to get better feedback.

Izvorni jezik
Engleski

Znanstvena područja
Farmacija

POVEZANOST RADA